Search

everythinglearnresearchcommunity

for

Search:↓

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Bicalutamide may reduce hair shedding in women but needs longer trials to confirm its effectiveness.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Skin symptoms often reveal hormonal imbalances in PCOS.

Hormones significantly affect hair growth and loss, requiring personalized treatment.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Women with Polycystic Ovary Syndrome (PCOS) have a higher risk of developing type 2 diabetes due to insulin resistance.

PCOS is a common hormonal disorder with symptoms like irregular periods and excess hair growth, managed with lifestyle changes and medications.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

New genes and pathways are important for testosterone production and male sexual development.

Doctors are preparing to potentially perform uterus transplants in transgender women, considering technical, hormonal, and ethical factors.

High doses of testosterone disrupt hormone levels and receptor expression in the uterus, affecting fertility.

Male rats grow hair faster than females, and certain hormones can slow or slightly increase hair growth, but not significantly beyond natural rates.

Non-classical 21 hydroxylase deficiency is an underdiagnosed cause of female hair loss and polycystic ovarian syndrome.

Long-term healthy eating lowers testosterone and improves health in women with suspected PCOS.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.